Autolus Therapeutics (AUTL) Selling, General & Administrative (2017 - 2026)
Autolus Therapeutics' Selling, General & Administrative was $41.16 million in Q2 2026, up 36.0% from $30.27 million a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Selling, General & Administrative (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Autolus Therapeutics' Selling, General & Administrative was $143.5 million through Jun 30, 2026, up 18.2% year-over-year; for FY2025, it came in at $131.87 million, up 29.6% from FY2024.
- Selling, General & Administrative has now increased for four consecutive years, with a five-year compound annual growth rate of 30.4% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $101.72 million in FY2024 (+117.6%), $46.75 million in FY2023 (+46.5%), $31.9 million in FY2022 (+0.1%) and $31.87 million in FY2021 (-8.9%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2018.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2024 (growth of 157.6%); the worst was Q4 2021 (a decline of 15.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Autolus Therapeutics | 468.91 Mn | -511.27 Mn | 23.31 Mn | 35.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35.95 Mn |
| Jun 30, 2026 | 41.16 Mn |
| Mar 31, 2026 | 39.95 Mn |
| Dec 31, 2025 | 35.79 Mn |
| Sep 30, 2025 | 36.28 Mn |
| Jun 30, 2025 | 30.27 Mn |
| Mar 31, 2025 | 29.54 Mn |
| Dec 31, 2024 | 34.31 Mn |
| Sep 30, 2024 | 27.33 Mn |
| Jun 30, 2024 | 21.90 Mn |
| Mar 31, 2024 | 18.18 Mn |
| Sep 30, 2023 | 10.61 Mn |
| Jun 30, 2023 | 11.12 Mn |
| Mar 31, 2023 | 9.28 Mn |
| Dec 31, 2022 | 7.41 Mn |
| Sep 30, 2022 | 8.23 Mn |
| Jun 30, 2022 | 8.27 Mn |
| Mar 31, 2022 | 7.99 Mn |
| Dec 31, 2021 | 7.59 Mn |
| Sep 30, 2021 | 8.30 Mn |
API Access
Autolus Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();